The Alliance for mRNA Medicines (AMM) brings together senior executives and top decision-makers in the mRNA industry to advance pioneering research into vaccines and therapies for patients. The annual meeting features one-on-one partnering opportunities for companies and investors, dedicated networking, keynotes and fireside chats featuring KOLs and industry visionaries, as well as engaging plenary and panel discussions among biotech, pharma, and academic leaders.
November 13–15, 2024
Hilton Boston Park Plaza Hotel
50 Park Plaza, Boston, MA 02116, USA
Through the power of the partneringONE partnering platform, attendees can search, connect, and schedule 1:1 meetings with potential partners to identify opportunities, build relationships, and move deals forward.
Ample dedicated networking opportunies to connect with other industry leaders and potential partners.
Learn from senior executives and top decision-makers in the mRNA industry to advance pioneering research into vaccines and therapies for patients with engaging speakers, fireside chats, and panel discussions.
Lorem ipsum dolor sit amet, consectetur
Lorem ipsum dolor sit amet, consectetur
Lorem ipsum dolor sit amet, consectetur
Lorem ipsum dolor sit amet, consectetur
Lorem ipsum dolor sit amet, consectetur
Lorem ipsum dolor sit amet, consectetur
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering mRNA industry leaders, innovators, scientists, and other key stakeholders.